MEDICYTE GMBH has a total of 14 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), China and Germany. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are CELOGOS, AXORDIA LTD and GALAPAGOS GENOMICS NV.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | China | 2 | |
#3 | Germany | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Analysing materials | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Braspenning Adrianus J C M | 8 |
#2 | Kuepper Jan-Heiner | 6 |
#3 | Noerenberg Astrid | 5 |
#4 | Heinz Stefan | 5 |
#5 | Hewitt Nicola | 5 |
#6 | Kuepper Heiner | 3 |
#7 | Kuhn Anne | 3 |
#8 | Holder Stefan | 3 |
#9 | Kandolf Reinhard | 2 |
#10 | Küpper Jan-Heiner | 1 |
Publication | Filing date | Title |
---|---|---|
EP2927685A1 | Suitable hepatocytes for in-vitro hepatitis tests | |
DE102010041958A1 | Suitable hepatocytes for in vitro genotoxicity tests | |
DE102007041655A1 | Propagation of primary cells and their use | |
AU2006235868A1 | Reversible immortalization | |
EP1660641A1 | Follicular fluid for prolonged growth and survival of cells for cell therapies |